Skip to main content

UBS Group AG

Position in TXG — 10x Genomics, Inc.

CIK 1610520 ZURICH, V8

Position in TXG

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$10,503,796
-$3,539,112 QoQ
Shares Held
494,762
-42.5% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 84.40846305900614.ToString("F0")% Shared 0.ToString("F0")% None 15.591536940993853.ToString("F0")%

Common Shares in TXG Over Time

Shares Held

Position Value (USD)

Derivatives in TXG

reported options exposure · as of Jun 30, 2020
CallValue
$893,100
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Health Information Services

Healthcare · as of Mar 31, 2026

UBS Group AG holds $592,914,921 across 45 Health Information Services names. TXG ranks #11 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TXG

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,503,796 494,762
2025-12-31 $14,042,908 861,000
2025-09-30 $8,872,475 758,980
2025-06-30 $10,618,591 916,977
2025-03-31 $7,270,237 832,788
2024-12-31 $3,784,245 263,527
2024-09-30 $5,526,542 244,754
2024-06-30 $2,947,782 151,557
2024-03-31 $2,036,639 54,267
2023-12-31 $348,574 6,229
2023-09-30 $458,328 11,111
2023-06-30 $551,866 9,883
2023-03-31 $1,253,712 22,472
2022-12-31 $178,446 4,897
2022-09-30 $53,200 1,868
2022-06-30 $132,717 2,933
2022-03-31 $1,821,190 23,941
2021-12-31 $4,631,314 31,091
2021-09-30 $4,227,933 29,042
2021-06-30 $4,855,747 24,797
2021-03-31 $5,489,187 30,327
2020-12-31 $5,164,434 36,472
2020-09-30 $8,035,874 64,452
2020-06-30 $3,034,842 33,981
2020-06-30 $893,100 10,000
2020-03-31 $1,767,332 28,359